ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd
SSE:603976
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (3.9), the stock would be worth ¥15.84 (25% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 5.2 | ¥21.23 |
0%
|
| 3-Year Average | 3.9 | ¥15.84 |
-25%
|
| 5-Year Average | 4.2 | ¥17.35 |
-18%
|
| Industry Average | 3.8 | ¥15.49 |
-27%
|
| Country Average | 3.3 | ¥13.53 |
-36%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
¥3.2B
|
/ |
Oct 2025
¥649.2m
|
= |
|
|
¥3.2B
|
/ |
Dec 2025
¥860.9m
|
= |
|
|
¥3.2B
|
/ |
Dec 2026
¥916.9m
|
= |
|
|
¥3.2B
|
/ |
Dec 2027
¥976.5m
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd
SSE:603976
|
3.2B CNY | 5.2 | 181.9 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.9T JPY | 10.2 | 39.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.1B USD | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.2B CHF | 3.8 | 37.2 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
91B DKK | 4 | 23.2 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.7B USD | 2.9 | 30.8 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.2B GBP | 2.9 | 32.2 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
905.8B JPY | 6.6 | 51.2 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 2 | -15.4 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.3T KRW | 99.2 | -37.8 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
37.7B CNY | 3.3 | 22 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.7 |
| Median | 3.3 |
| 70th Percentile | 6.2 |
| Max | 5 034 353.9 |
Other Multiples
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd
Glance View
Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd. engages in the research, development, production, and sale of medicinal packaging materials such as medicinal glass tubes. The company is headquartered in Chongqing, Chongqing and currently employs 1,755 full-time employees. The company went IPO on 2017-08-22. The Company’s principal products include antibiotic glass bottles, oral liquid bottles, as well as medicine packing bottle caps. The Company’s products are mainly applied in the packing of biological agent, traditional Chinese medicines, hydro-acupuncture of chemical preparation, oral liquid, as well as health products, among others. The firm mainly distributes its products in mainland China.
